Smoore's 2023 H1 Financial Report: Revenue at 5.123 Billion Yuan with Over 90% from Overseas Markets


Smoore's 2023 H1 Financial Report: Revenue at 5.123 Billion Yuan with Over 90% from Overseas Markets


On August 21st, electronic vaporization giant Smoore unveiled its 2023 mid-year performance announcement. According to the financial report, Smoore achieved a total revenue of 5.123 billion Chinese Yuan in the first half of 2023, marking a 9.4% decrease compared to the previous year. After adjustments, the net profit reached 758 million Yuan.

Enterprise Client Business (ODM) Revenue at 44.74 Billion Yuan, Accounting for 87.3% of Total Revenue, with Robust Growth in Overseas Markets

The Enterprise Client Business (ODM) segment reported revenue of 44.74 billion Yuan, representing a significant portion of 87.3% of the total revenue. Notably, there was a substantial 30% year-on-year growth in overseas market revenue. In the United States, revenue accounted for 40.2%, experiencing a substantial growth of 27.7%.

Furthermore, revenue from European and other markets showed an impressive 32% year-on-year increase. Particularly, the rapid shipment of disposable products led to an astounding 369% year-on-year revenue growth.

The report also highlights significant variations in Smoore Group's sales performance across different global markets:

United States Market: Revenue growth attributed to maintaining the top market share in the closed-system cartridge products for large customers and further enhancements.

Domestic Market: A significant decline, experiencing a steep drop of 96.3% compared to the same period last year.

European and Other Markets: Significant growth due to the upgraded ceramic vaporization core technology platform, FEELM Max, resulting in a substantial increase in revenue share from disposable products.

ODM vape

Regarding research and development, Smoore continued to invest heavily, exceeding 600 million Yuan, representing a 1.8% increase from the previous year. Electronic vaporization products and heated non-combustion products accounted for the highest share of R&D expenditure at 68.1%, followed by specialized vaporization products and vaporization medical and beauty products.

Of particular note is the increased R&D expenditure for vaporization medical and beauty products, which rose from 4.3% in previous years to 18.5%. This indicates Smoore's intention to explore new avenues in the field of vaporization medical and beauty products.

Get the latest price? We will reply as soon as possible (within 12 hours)